Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626496 · ClinicalTrials.gov registry record
Family Study of Lymphoproliferative Disorders
A clinical trial of Multiple Myeloma and Lymphoma, Non-Hodgkin, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 3,000
- Enrollment target
- 1
- Study location
NCT00626496 is a study of Multiple Myeloma and Lymphoma, Non-Hodgkin that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 3,000 participants, above the 540-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (456% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00626496, a study of Multiple Myeloma and Lymphoma, Non-Hodgkin, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 3,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic leukemia and non-Hodgkin lymphoma. Since there is evidence that these cancers cluster in families, this study aims to understand how genetics and environmental exposures contribute to the development of these cancers.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2004-04-01 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00626496
The ClinicalTrials.gov registry entry for NCT00626496 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 540-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (456% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Multiple Myeloma appearing as the primary indexed condition, and to 0 interventions.
NCT00626496 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT00626496 about?
NCT00626496 is a clinical study titled "Family Study of Lymphoproliferative Disorders". Blood and lymph node cancers can begin in either the lymphatic tissues (as in the case of lymphoma) or in the bone marrow (as with leukemia and myeloma), and they all are involved with the uncontrolled growth of white blood cells. There are many subtypes of these cancers, e.g., chronic lymphocytic l...
What is the current status of trial NCT00626496?
This trial is currently recruiting. The enrollment target is 3,000 participants. The study started on 2004-04-01. Estimated completion is 2029-12-31.
What conditions does trial NCT00626496 study?
This clinical trial studies the following conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Monoclonal B-Cell Lymphocytosis.
Who is sponsoring clinical trial NCT00626496?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00626496 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.